The Morning Blunt
Volume 1| Issue 26
September 26, 2018
“I am not a product of my circumstance. I am a product of my decisions”
— Stephen Covey
Canadian cannabis regulations are allowing banks to play a vital role in deal making for cannabis companies. Banking institutions are offering to provide banking services, liaison deals, and assist in M&As. Currently Canadian banks are doing some of the largest deals in the cannabis industry due to legalization, which has also attracted many from the US market.
Portfolio manager Patrick Horan and Michael Kors discuss the difficulties of investing in a rapidly evolving sector such as the cannabis industry.
As pot stocks become more popular venture capital funds and exchange traded funds are expanding to the cannabis industry. The US federal government’s stance on cannabis might be a reason to wait to invest in the industry however.
Cannabis Elevated is a podcast dedicated to the cannabis industry. Listen to industry leaders discuss extraction, business, and the evolution behind operating a cannabis business in an ever changing landscape.
Aurora Cannabis announced that it is unequivocally ready for Oct. 17. Aurora is ahead of schedule in terms of it’s cannabis supply and says it can serve all provinces and territories. Aurora estimates that by the end of the year they will produce 150,000 kilograms of cannabis annually.
An Interview with Cronos CEO Michael Gorenstein tells Bloomberg that he sees the global cannabis market opening up rapidly. Gorenstien discusses the Cronos brand and their plans to produce cannabinoids.
Tilray led cannabis stocks Tuesday after announcing plans to export cannabis to Australia for epileptic children. Canopy received a buy rating and $100 street-high price target from Benchmark, while Aurora also soared after news of tripling their revenues in the fourth quarter.
Mallory Czuchra of National Cannabis Insurance discusses insurance options and protections for businesses. Check out NCIA’s podcast discussing options and regulations surrounding the industry.
Recently over 30% of California’s cannabis products failed testing for potency, mold, pesticides, and other precautionary tests. However a majority of the failures simply did not meet packaging standards or failed to have consistent potency levels within a 10% margin of error. Take a look at what experts are saying about the flaws in the testing system.
Ohio’s Green Growth Brands, a cannabis firm backed by the Schottenstein, raised $65M as it ramps up to be publicly traded in Canada. Green Growth intends to expand it’s operation to Massachusetts, Florida, and New Jersey.
According to Sonoma County California, code enforcement shut down over 600 illegal cannabis operators since last year. The efforts to combat illicit producers has been a top priority for concerned citizens. However licensure issues may be partly to blame.
While California finalizes it’s cannabis regulations emergency measures have been implemented to prevent disruption to the industry. One of these measures allows cannabis delivery services to deliver products to anyone with a valid CA driver’s license. However many citizens are uniting against the new regulations, saying delivery companies pose a public safety issue.
The answer is maybe. While there is evidence that CBD relieves anxiety and epileptic symptoms, not enough research has been conducted on the effects of CBD alone. Researchers have difficulties procuring CBD because of it’s schedule one status and limited availability. Explore this article for an in-depth analysis on what CBD is known to actually do and why research is slow going.